The FDA clearance permits the motion-preserving device to be implanted across two levels in the cervical spine.

With this approval, pro disc® C Nova joins pro disc C Vivo and pro disc C SK as three distinct pro disc cervical TDR devices ...

Centinel Spine receives US FDA approval for two-level use of prodisc C Nova cervical total disc replacement device: West Chester, Pennsylvania Thursday, October 15, 2026, 17:00 Hr ...

Worldwide Q3 2025 prodisc® Total Disc Replacement (TDR) revenue exceeds $30 million for the second consecutive quarter. Record worldwide prodisc Cervical TDR revenue of nearly $20 million in Q3 2025, ...

Worldwide prodisc® Total Disc Replacement (TDR) revenue nearing $28 million in Q1 2025, growing 33% over prior year. Record worldwide prodisc Cervical TDR revenue of $17 million in Q1 2025, growing 28 ...

Record full-year 2024 prodisc® Total Disc Replacement (TDR) revenue of over $95 million in sales, up 38% over prior year. Full-year 2024 prodisc TDR sales broke records in both U.S. and International ...

This study expands the evidence validating the fixed-core design of the prodisc L device and includes 1,187 patients undergoing 1- or 2-level LTDR, with and without prior surgery, and followed from 7 ...

WEST CHESTER, Pa., April 20, 2023 /PRNewswire/ -- Centinel Spine®, LLC, ("the Company") a leading global medical device company addressing cervical and lumbar spinal disease by providing the most ...

WEST CHESTER, Pa., Oct. 12, 2023 /PRNewswire/ -- Centinel Spine ®, LLC, ("the Company") the leading global medical device company addressing cervical and lumbar spinal disease with the most clinically ...

WEST CHESTER, Pa., Dec. 14, 2022 /PRNewswire/ -- Centinel Spine ®, LLC, ("the Company") a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical ...

Centinel Spine LLC announced it has received FDA approval for two-level use of the prodisc C Nova cervical total disc ...